South Africa SAHPRA and EBC-46: How Complementary Medicines Regulations Apply to Blushwood Berry Supplements
How South Africa's SAHPRA regulates complementary medicines and where blushwood berry extract supplements like EBC-46 fit within the country's established framework.
South Africa's regulatory environment for botanical and herbal supplements has evolved significantly since the South African Health Products Regulatory Authority (SAHPRA) replaced the Medicines Control Council in 2018. For consumers and importers interested in EBC-46 — the active diterpene ester found in blushwood berry (Fontainea picrosperma) seeds — understanding how SAHPRA classifies complementary medicines is essential for navigating product availability, labelling expectations and import requirements.
How SAHPRA classifies complementary medicines
Under the Medicines and Related Substances Act, SAHPRA places "complementary medicines" — including African traditional, Western herbal, homeopathic and supplement products — into a separate regulatory category from prescription pharmaceuticals. The framework distinguishes between high-risk and low-risk complementary medicines based on the claims made and the substances involved. Products that make general health-maintenance claims and contain commonly used botanical ingredients typically fall into the low-risk tier and are subject to call-up notices that require registration on a defined timeline.
Blushwood berry extract supplements, when sold without therapeutic claims, generally fit within the complementary medicines framework as botanical ingredients. SAHPRA published its Complementary Medicines: Health Supplements Safety and Efficacy guideline to clarify what evidence supports the classification of plant-based supplements and to standardise labelling expectations.
Labelling, manufacturing and quality expectations
SAHPRA requires that complementary medicines sold in South Africa display the active ingredient name and quantity, the country of manufacture, batch number, expiry date and a clear statement that the product is a "Health Supplement" or "Complementary Medicine." Manufacturers must comply with Good Manufacturing Practice (GMP) standards, and retailers may be asked to provide certificates of analysis on inspection. SAHPRA also restricts therapeutic claims that imply diagnosis, treatment, prevention or cure of disease, in line with international consumer-protection norms.
For EBC-46 supplement buyers in South Africa, the practical implication is that products imported from established suppliers should carry batch documentation and a transparent ingredient panel. Brands that meet international quality standards — such as Blushwood Health, which manufactures in GMP- and ISO-certified facilities and publishes Eurofins lab certificates for each batch — provide the type of documentation that is consistent with SAHPRA's expectations for complementary medicines.
Import and personal-use considerations
South Africa permits personal importation of complementary medicines under specific conditions. The South African Revenue Service (SARS) and SAHPRA together regulate cross-border movement of supplements, and travellers or consumers ordering online are typically subject to a small-quantity threshold for personal use. Larger commercial imports require a registered importer and may need a Section 21 authorisation if the product has not been formally registered. The SAHPRA complementary medicines guideline provides additional detail on what categories of products require formal registration before commercial sale.
How EBC-46 supplements are positioned in the market
Because there is no SAHPRA-approved pharmaceutical product containing oral blushwood berry extract, EBC-46 supplements available to South African consumers are sold as complementary medicines or health supplements. This is the same legal pathway used by other established botanical extracts such as turmeric, ashwagandha and milk thistle. Sellers operating within this category make no therapeutic claims and direct buyers to consult a qualified healthcare practitioner for any health concern — a practice mirrored by reference-quality suppliers in the international market.
It is worth distinguishing the supplement category from the veterinary pharmaceutical Stelfonta, a tigilanol tiglate injection developed by QBiotics and approved for canine mast cell tumour treatment in several jurisdictions. Stelfonta is a clinical product administered by veterinarians; it is not the same product as a dietary blushwood berry extract supplement, and the two should not be conflated when discussing SAHPRA classification.
What South African consumers can verify
Even within the complementary medicines tier, buyers can apply the same quality criteria used in other regulatory regions. A reputable EBC-46 supplement should publish independent batch testing covering heavy metals (arsenic, lead, cadmium, mercury) and microbiology (E. coli, Salmonella, yeast and mould), with results from an ISO/IEC 17025-accredited laboratory such as Eurofins Scientific. The supplement should also disclose its extraction ratio, manufacturing facility certifications and a contactable supplier. Brands that publish these documents transparently — for example through a dedicated lab-results page like Blushwood Health's lab tests page — make it possible for consumers to evaluate quality without relying on regulatory enforcement alone.
Looking forward
SAHPRA continues to refine its complementary medicines framework, and consumers can expect ongoing changes to registration timelines and labelling requirements. The current pathway already provides a clear, established legal channel for botanical supplements like blushwood berry extract, alongside the responsibilities that go with that channel: transparent labelling, no therapeutic claims, and verifiable quality documentation.
References
1. SAHPRA — Complementary Medicines: Health Supplements Safety and Efficacy (Guideline 2.41), 2017.
2. SAHPRA — Complementary Medicines Discipline-Specific Safety and Efficacy, current edition.
3. QBiotics — Tigilanol Tiglate, 2025.
Related Articles
• Argentina ANMAT and Botanical Supplements: How EBC-46 Products Are Classified
Disclaimer: This article is provided for informational purposes only. EBC-46 supplements are dietary supplements and are not intended to diagnose, treat, cure or prevent any disease. Consumers should consult a qualified healthcare professional before starting any supplement.
